Abstract:Aim: The main purpose of the research is to develop a effective, sensitive, economical and simple reverse phase HPLC method for the determination of genotoxic N-Nitrosamine's impurities in Efavirenz drug substance. Study Design: HPLC based quantification studies Place and Duration of Study: Department of Chemistry, Acharya Nagarjuna University, Guntur, Andhra Pradesh between April 2022 and August 2022. Methodology: Determination of genotoxic N-Nitrosamine's in Efavirenz drug substance. N-Nitrosamine's impurities were determined by RP-HPLC method using Zorbax SB C18 (150x4.6mm, 3.5μ) column as stationary phase. Column temperature maintained 25°C, injection volume 20 μL, flow rate 1.0 mL/min and sample cooler temperature 5°C and run time was 15 minutes. The mixture of 0.1% formic acid buffer and methanol in the ratio of 50:950 (v/v) was used as mobile phase. wavelength 240 nm. respectively. Results: There is no interference of blank at N-Nitrosamine's impurities peaks. The elution order and the retention times of impurities and Efavirenz obtained from individual standard preparations and mixed standard preparations are comparable. The limit of detection (LOD) and limit of quantitation (LOQ) for NDMA 0.03 & 0.09 μg/mL, NDEA 0.02 & 0.06 μg/mL and NDIPA 0.03 & 0.09 μg/mL respectively. The linearity results for N-Nitrosamine's impurities in the specified concentration range are found satisfactory, with a correlation coefficient greater than 0.99.Calibration curve was plotted and correlation co-efficient for impurities found to be 1.000, 1.000 and 1.000 respectively. The accuracy studies were shown as %recovery for N-Nitrosamine's impurities at specification level. The limit of % recovered shown is in the range of 80 and 120% and the results obtained were found to be within the limits. Hence the method was found to be accurate. The technique has been validated in accordance with ICH rules, and all validation parameters meet the acceptance criteria of the ICH Q2 specification. Conclusion: According to ICH guidelines, an RP-HPLC method that can assess genotoxic Nitrosoamines in Efavirenz at trace level concentration has been established. The method's specificity, precision, linearity, and accuracy ensured its efficacy. As a result, the technique is appropriate for the goals it was designed to achieve and can be successfully used for release testing of efavirenz into the market.

Determination of serum nevirapine by RP-HPLC

Study on determination method of the residues of Tirofiban Hydrochloride on cleaning validation

Application of thioglycolic acid capped nano-ZnS as a fluorescence probe for the determination of nevirapine

Content Determination of Rifabutin by HPLC

RP-HPLC Determination of the Content of Lopinavir and Its Related Substances

Determination the concentration of nevirapine,lamivudine,stavudine,zidovudine,efavirenz in human plasma for simultaneous quantification by HPLC-MS/MS

Determination of Voriconazole in Plasma from Patients of AIDS Complicated with Pulmonary Fungal Infection by RP-HPLC

Determination of Fluconazole Concentration in Human Serum by RP-HPLC and Its Clinical Application

DEVELOPMENT AND VALIDATION OF A METHODOLOGY FOR THE ANALYSIS OF RITONAVIR AND LOPINAVIR IN COMBINED DOSAGE FORM BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY

Determination of Ziprasidone Hydrochloride by RP-HPLC with UV Detection

Electrochemical Oxidation and Determination of Antiretroviral Drug Nevirapine Based on Uracil-Modified Carbon Paste Electrode

Determination of the concentration of voriconazole in human plasma by HPLC

A high performance liquid chromatography method for the quantitative determination of ribavirin in human plasma and its application in a pharmacokinetics study

Determination of nelfinavir mesylate as bulk drug and in pharmaceutical dosage form by stability indicating HPLC.

Determination of Nifeviroc and Its Stability in Hydroxypropyl-Β-cyclodextrin Inclusion Complex

Determination of Voriconazole for Injection by HPLC

Determination of Fluconazole in Human Plasma by RP-HPLC

Green HPLC quantification method of lamivudine, zidovudine and nevirapine with identification of related substances in tablets

Determination of Vancomycin and Norvancomycin in human serum by HPLC

Determination of voriconazole in human plasma by high-performance liquid chromatography and its pharmacokinetics

Determination of Genotoxic Impurities N-nitrosamine's in Efavirenz Drug Substance Using Rp-Hplc Technique